These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34585128)

  • 1. The influence of equitable access policies and socioeconomic factors on post-liver transplant survival.
    Huang DC; Fricker ZP; Alqahtani S; Tamim H; Saberi B; Bonder A
    EClinicalMedicine; 2021 Nov; 41():101137. PubMed ID: 34585128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial, ethnic, and socioeconomic disparities impact post-liver transplant survival in patients with hepatocellular carcinoma.
    Huang DC; Yu RL; Alqahtani S; Tamim H; Saberi B; Bonder A
    Ann Hepatol; 2023; 28(5):101127. PubMed ID: 37286167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnicity-Specific Differences in Liver Transplant Outcomes Among Adults With Primary Sclerosing Cholangitis: 2005-2017 United Network for Organ Sharing/Organ Procurement and Transplantation Network.
    Bayable A; Ohabughiro M; Cheung R; Wong RJ
    J Clin Exp Hepatol; 2021; 11(1):30-36. PubMed ID: 33679046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of socioeconomic factors on liver transplant survival outcomes in patients with autoimmune liver disease in the United States.
    Sierra L; Marenco-Flores A; Barba R; Goyes D; Ferrigno B; Diaz W; Medina-Morales E; Saberi B; Patwardhan VR; Bonder A
    Ann Hepatol; 2024; 29(3):101283. PubMed ID: 38151060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethnicity and Insurance-Specific Disparities in the Model for End-Stage Liver Disease Score at Time of Liver Transplant Waitlist Registration and its Impact on Mortality.
    Robinson A; Hirode G; Wong RJ
    J Clin Exp Hepatol; 2021; 11(2):188-194. PubMed ID: 33746443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of donor
    Kozlitina J; Cohen NM; Sturtevant D; Cohen JC; Murphey-Half C; Saltarrelli JG; Jindra P; Askar M; Hwang CS; Vagefi PA; Lacelle C; Hobbs HH; MacConmara MP
    EClinicalMedicine; 2024 Jan; 67():102350. PubMed ID: 38169797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver Transplantation in India: At the Crossroads.
    Nagral S; Nanavati A; Nagral A
    J Clin Exp Hepatol; 2015 Dec; 5(4):329-40. PubMed ID: 26900275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database.
    Rifai G; Anani A; Hanouneh IA; Mohamad B; Matloob A; Lopez R; Zein NN; Alkhouri N
    Transplant Proc; 2016 Dec; 48(10):3362-3367. PubMed ID: 27931582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inferior Liver Transplant Outcomes during early COVID-19 pandemic in United States.
    Okumura K; Nishida S; Sogawa H; Veillette G; Bodin R; Wolf DC; Dhand A
    J Liver Transpl; 2022; 7():100099. PubMed ID: 38013989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor Factors Including Donor Risk Index Predict Fibrosis Progression, Allograft Loss, and Patient Survival following Liver Transplantation for Hepatitis C Virus.
    Jesudian A; Desale S; Julia J; Landry E; Maxwell C; Kallakury B; Laurin J; Shetty K
    J Clin Exp Hepatol; 2016 Jun; 6(2):109-14. PubMed ID: 27493458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database.
    Wong RJ; Ahmed A
    Clin Transplant; 2014 Jul; 28(7):755-61. PubMed ID: 24750171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UNOS Liver Registry: ten year survivals.
    Waki K
    Clin Transpl; 2006; ():29-39. PubMed ID: 18368704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Race/ethnicity is associated with ABO-nonidentical liver transplantation in the United States.
    Ge J; Roberts JP; Lai JC
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28517242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living-Donor Liver Transplant and Improved Post-Transplant Survival in Patients with Primary Sclerosing Cholangitis.
    Sierra L; Barba R; Ferrigno B; Goyes D; Diaz W; Patwardhan VR; Saberi B; Bonder A
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends and outcomes of liver transplantation among older recipients in the United States.
    Okumura K; Lee JS; Dhand A; Sogawa H; Veillette G; John D; Misawa R; Bodin R; Wolf DC; Diflo T; Nishida S
    World J Transplant; 2022 Aug; 12(8):259-267. PubMed ID: 36159074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of obesity and diabetes on waitlist survival, probability of liver transplantation and post-transplant survival among chronic hepatitis C virus patients.
    Aguilar M; Liu B; Holt EW; Bhuket T; Wong RJ
    Liver Int; 2016 Aug; 36(8):1167-75. PubMed ID: 26858016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States.
    Yang JD; Larson JJ; Watt KD; Allen AM; Wiesner RH; Gores GJ; Roberts LR; Heimbach JA; Leise MD
    Clin Gastroenterol Hepatol; 2017 May; 15(5):767-775.e3. PubMed ID: 28013117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Status at Liver Transplant Waitlisting Correlates With Greater Odds of Encephalopathy, Ascites, and Spontaneous Bacterial Peritonitis.
    McCabe P; Hirode G; Wong R
    J Clin Exp Hepatol; 2020; 10(5):413-420. PubMed ID: 33029049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver Transplant Survival Index for Patients with Model for End-Stage Liver Disease Score ≥ 35: Modeling Risk and Adjusting Expectations in the Share 35 Era.
    Steggerda JA; Kim IK; Todo T; Malinoski D; Klein AS; Bloom MB
    J Am Coll Surg; 2019 Apr; 228(4):437-450.e8. PubMed ID: 30594593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.